The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Gut-on-a-Chip Provides Insight into Microbiome & Intestinal Inflammation

Gut-on-a-Chip Provides Insight into Microbiome & Intestinal Inflammation

February 8, 2016 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

GENERIC_Science_Research_500x270Harvard researchers have created a living, human-gut-on-a-chip that can be used to study the role of the microbiome in gut pathophysiology. The microdevice makes it possible to dissect disease mechanisms in a controlled manner and represents a marked advance over current in vitro systems and animal models. Hyun Jung Kim, PhD, now an assistant professor at the University of Texas in Austin, and colleagues published a description of their human gut-on-a-chip on Dec. 9, 2015, in the Proceedings of the National Academy of Sciences.

You Might Also Like
  • Volatility of the Gut Microbiome Tied to IBD
  • Dysbiosis of Gut, But Not Ocular Microbiome, Associated with Sjögren’s Syndrome
  • The Gut Microbiome Influences Postmenopausal Bone Loss
Also By This Author
  • Researchers Identify Molecule That Promotes Osteogenesis

The chip includes Caco-2 intestinal epithelial cells that were originally isolated from a human colorectal tumor in a stable ecosystem with gut bacteria and immune cells. The gut-on-a-chip should provide insights into inflammatory bowel disease (IBD) and ileus. It can be used to define potential therapeutic targets for these conditions and test drug candidates. The gut-on-a-chip should also facilitate evaluation of the growth and treatment of pathogenic bacteria, including the role of physiological mechanical deformation in the induction of small intestinal bacterial overgrowth (SIBO).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The human gut microbiome is believed to play a critical role in the control of gut homeostasis, immune modulation and pathology. Experts believe that chronic intestinal inflammation results from the recruitment of peripheral blood mononuclear cells (PBMCs) into the lamina propria. The chip makes it possible to study this process more closely. In their paper, the researchers describe their investigation of SIBO, the resulting lipopolysaccharides (LPS) and inflammation.

LPS is found in the outer membrane of gram-negative bacteria. It acts as an endotoxin in mammals and promotes the secretion of pro-inflammatory cytokines, nitric oxide and eicosanoids. Although LPS is often present in the human intestine, the levels are generally considered harmless, possibly due to the fact that LPS can, at least partially, be inactivated by mammalian cell-derived acyloxyacyl hydrolase. The gut-on-a-chip allowed the scientists to investigate this process more closely.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Using this microdevice, we also discovered that immune cells must be present along with LPS or nonpathogenic bacteria to induce production of a key set of proinflammatory cytokines (IL-8, IL-6, IL-1β and TNF-α) that act together to produce villus injury and intestinal barrier disruption,” write the authors in their discussion. “However, although our results confirm that IL-6, IL-1β and TNF-α may contribute to development of intestinal inflammatory disease as suggested in the past based on in vivo studies, our ability to manipulate these factors independently revealed that these cytokines must act in the presence of high levels of IL-8 to exert these disease-promoting effects. This novel result would be difficult to detect using animal models.”

Pages: 1 2 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: gut microbiome, inflammatory bowel disease, Microbiome, pathology

You Might Also Like:
  • Volatility of the Gut Microbiome Tied to IBD
  • Dysbiosis of Gut, But Not Ocular Microbiome, Associated with Sjögren’s Syndrome
  • The Gut Microbiome Influences Postmenopausal Bone Loss
  • Titanium Dioxide Additives May Boost Intestinal Inflammation

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)